Physician

Kevin R Kristl, M.D.

According to 2025 Medicare claims, Kevin Kristl, M.D. (NPI: 1811941768) practices neurology in the South Bend-Mishawaka, IN-MI market, with the plurality of this provider's patient population coming from St. Joseph, IN. This provider's primary affiliated billing organization is MICHIANA NEUROLOGIC MEDICINE, PC (NPI: 1336414499; TIN: 35-2004112) and primary practice location at 46545-4300. Kristl is affiliated with the Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403) and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Kristl's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 423 traditional Medicare patients, billed 31,159 HCPCS/CPT codes, and received $548,412 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 9,752 prescription claims across 727 beneficiaries totaling $7,198,943 in drug costs, led by Gammaplex (Immun Glob G(Igg)/Gly/Iga 0-50). DME data shows 48 claims. Open Payments data shows 286 records totaling $5,692. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $158,655 to $548,412. Similarly, Part D prescription costs have risen steadily, from $4,116,319 to $7,198,943. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,543 and ending at $23,576.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	692	1,945	$158,655
2016	656	1,821	$161,287
2017	664	1,821	$147,764
2018	581	2,711	$143,403
2019	511	1,583	$118,587
2020	460	1,062	$100,754
2021	437	1,036	$111,902
2022	427	1,065	$111,536
2023	412	10,904	$337,912
2024	423	31,159	$548,412

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	709	10,675	$4,116,319
2016	718	11,654	$4,463,766
2017	766	12,308	$4,637,590
2018	736	11,284	$4,687,404
2019	742	10,506	$5,353,151
2020	712	10,264	$5,110,353
2021	681	10,027	$5,609,463
2022	671	10,054	$6,645,168
2023	694	9,702	$6,936,154
2024	727	9,752	$7,198,943

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$1,702
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	20	$344
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	48	$70,065

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95819	Measurement of brain wave activity (eeg), awake and asleep	51	51	$291
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	112	112	$135
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	159	221	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	288	437	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	65	66	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammaplex	Immun Glob G(Igg)/Gly/Iga 0-50	49	1,029	$467,497
Ingrezza	Valbenazine Tosylate	57	1,710	$462,252
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	29	609	$401,474
Vumerity	Diroximel Fumarate	41	1,230	$365,444
Gammaked	Immune Globul G/Gly/Iga Avg 46	28	784	$261,688

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	12	$68,849
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	12	$920
E0779	Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater	Y	N/R	12	$172
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	12	$123

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	286	$5,692	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin R. Kristl, M.D.?

Tedicare shows public-source Medicare data for Kevin R. Kristl, M.D. (NPI 1811941768), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin R. Kristl, M.D. have ACO affiliation data?

Kevin R. Kristl, M.D. is shown with ACO affiliation data for Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403) and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Kevin R. Kristl, M.D.?

Kevin R. Kristl, M.D. is linked to MICHIANA NEUROLOGIC MEDICINE, PC (billing NPI 1336414499) in the available physician profile data.

Does Kevin R. Kristl, M.D. have Open Payments data?

Kevin R. Kristl, M.D. has 286 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.